Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.5B 521M 446M 418M 382M 721M 49.64B 728M 4.93B 1.92B 25.04B 1.96B 1.91B 82.94B P/E 2026 *
7.7x
P/E 2027 * 6.83x
Enterprise Value 3.5B 521M 446M 418M 382M 721M 49.64B 728M 4.93B 1.92B 25.04B 1.96B 1.91B 82.94B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.46x
Free-Float
45.7%
Yield 2026 *
5.86%
Yield 2027 * 6.59%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-10.02%
6 months-10.02%
Current year-29.30%
Current year 0.49
Extreme 0.4949
0.55
1 year 0.49
Extreme 0.4949
0.55
3 years 0.49
Extreme 0.4949
0.86
5 years 0.49
Extreme 0.4949
0.86
10 years 0.49
Extreme 0.4949
1.76
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-10.02%-.--% - - 523M
+1.01%+0.40%-13.25%-5.78% 13.14B
+1.98%-0.78%-34.62%-57.06% 4.85B
+1.85%-5.07%-6.29%-1.79% 4.56B
+1.58%-5.41%-0.92%-29.18% 3.94B
+1.01%-0.22%-22.48%+4.01% 3.54B
+2.21%+2.85%-9.38%-4.30% 3.35B
-0.47%-3.97%-13.59%+11.49% 3.29B
+0.86%-4.91%-19.29%-15.51% 2.38B
+1.82%-2.29%-29.53%-10.95% 1.66B
Average +0.18%-1.10%-16.59%-12.12% 4.52B
Weighted average by Cap. +1.13%-0.82%-15.36%-12.12%

Financials

2026 *2027 *
Net sales 6.98B 1.04B 890M 834M 762M 1.44B 99.03B 1.45B 9.84B 3.83B 49.96B 3.9B 3.82B 165B 7.56B 1.13B 964M 903M 825M 1.56B 107B 1.57B 10.66B 4.15B 54.12B 4.23B 4.13B 179B
Net income 454M 67.62M 57.94M 54.29M 49.6M 93.6M 6.45B 94.52M 640M 249M 3.25B 254M 248M 10.77B 514M 76.4M 65.47M 61.34M 56.03M 106M 7.28B 107M 724M 282M 3.67B 287M 281M 12.17B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.731CNY
Average target price
4.601CNY
Spread / Average Target
+68.47%

Annual profits - Rate of surprise